SMYD2 lysine methyltransferase regulates leukemia cell growth and regeneration after genotoxic stress-Reference-Cited by-同舟云学术

SMYD2 lysine methyltransferase regulates leukemia cell growth and regeneration after genotoxic stress

Published:2017-02-06 Issue:10 Volume:8 Page:16712-16727
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zipin-Roitman Adi¹,Aqaqe Nasma¹,Yassin Muhammad¹,Biechonski Shahar¹,Amer Mariam¹,van Delft Mark F.²³,Gan Olga I.²⁴,McDermott Sean P.²⁵,Buzina Alla⁶⁴,Ketela Troy⁶⁴,Shlush Liran²⁷,Xie Stephanie²⁴,Voisin Veronique⁶⁴,Moffat Jason⁶⁴,Minden Mark D.²⁸,Dick John E.²⁴,Milyavsky Michael¹

Affiliation:

1. Department of Pathology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

2. Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada

3. Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

4. Department of Molecular Genetics, University of Toronto, Toronto, Canada

5. Leidos Biomedical Research, Washington D.C., USA

6. Donnelly Centre for Cellular and Biomedical Research, University of Toronto, Toronto, Canada

7. Department of Immunology, Weizmann Institute of Science, Rehovot, Israel

8. Department of Medicine, University of Toronto, Toronto, Canada

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibiting SETD7 methyl‐transferase activity impairs differentiation, lipid metabolism and lactogenesis in mammary epithelial cells;FEBS Letters;2023-10-03

2. KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition;Leukemia;2023-01-31

3. SMYD2 Expression: Its Relationship to Cytogenetic and Prognosis in a Newly Diagnosed Childhood B-Acute Lymphoblastic Leukemia;Clinical Laboratory;2023

4. Oleocanthal Attenuates Metastatic Castration-Resistant Prostate Cancer Progression and Recurrence by Targeting SMYD2;Cancers;2022-07-21

5. KDM6A loss sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition;2022-07-13